Summary
To study the efficacy of intravenous immunoglobulin in symptomatic infection with human immunodeficiency virus (HIV) we enrolled 35 patients with CD4 lymphocyte counts below 300/μl in a randomized three-arm study. In addition to standard HIV treatment (e.g., zidovudine, aerosolized pentamidine), 13 patients were treated with 7.5 g and 11 with 40 g of a 7 S intravenous IgG preparation every 4 weeks over a period of 1 year. A control group of 11 patients remained on standard treatment. Clinical and laboratory parameters, including lymphocyte proliferation and in vitro immunoglobulin synthesis were evaluated prior to intravenous IgG administration. HIV-specific immunological abnormalities such as increased B-cell activation and B-cell immaturity were observed in all three study groups at the beginning of the study. Mitogen-induced lymphocyte proliferation was diminished. These disturbances were not influenced by intravenous IgG treatment. Further laboratory data and the course of the HIV infection (fever, antibiotic treatment, hospitalization, Candida and herpes simplex or cytomegalovirus infection) remained unchanged. Thus, our data with an observation period of 12 months do not support the use of intravenous IgG treatment in adult symptomatic HIV-infected patients with CD4 counts lower than 300/μl.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- ELISA:
-
enzyme-linked immunosorbent asay
- HIV:
-
human immunodeficiency virus
References
Additional SAS/STAT Procedures (1988) Release 6.03 SAS Technical Report P-179 SAS Institute Inc, Cary, NC, USA
Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A (1985) Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr 107:352–357
Buckley RH, Schiff RI (1991) The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 325:110–117
Büning H, Trenkler G (1978) Nichtparametrische statistische Verfahren. de Gruyter, Berlin New York
Brunkhorst U, Stürner M, Willers H, Deicher H, Schedel I, (1988) Efficacy of intravenous immunglobulins in patients with advanced HIV-1 infection. Infection 18:86–90
De Simone C, Cirelli A, Catania S, Ciardi M, Di Fabio S, Tzanzoglu S, Sorice F, Gargiulo M (1989) Immunopharmacological activity of intravenous gammaglobulins in AIDS and ARC patients. J Immunol Immunopharmacol 9:8–11
Hofmann B, Lindhardt BO, Gerstoft J, Petersen CS, Platz P, Ryder LP, Odum N, Dickmeiss E, Nielsen PB, Ullman S, Svejgaard A (1987) Lymphocyte transformation response to pokeweed mitogen as a predictive marker for the development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J 295:293–296
Hokland P, Ritz J, Schlossmann SF, Nadler LM (1985) Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol 135:1746–1751
Jacobson D, Mc Cutchan JA, Spechko PL, Abramson I, Smith RS, Bartok A, Boss GR, Durand D, Bozzette SA, Spector SA, Richman DD (1991) The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J Infect Dis 163:240–246
Janoff EN, Douglas JM, Gabriel M, Blaser MJ, Davidson AJ, Cohn DL, Judson FN (1988) Class-specific antibody response to Pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis 158:983–990
Katz IR, Krown SE, Safai B, Oettgen HF, Hoffmann MK (1986) Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome. Clin Immunol Immunopathol 39:359–367
Kehrl JH, Muraguchi A, Fauci AS (1984) Differential expression of cell activation markers after stimulation of resting human B lymphocytes. J Immunol 132:2857–2861
Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgy JV (1987) Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 138:3720–3724
Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, Clements ML (1989) The influence of HIV infection on antibody responses to a two-dose regimen of Influenza vaccine. JAMA 262:779–783
Müller F, Froland S, Brandtzaeg P (1989) Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human-immunodeficiency virus (HIV). Clin Exp Immunol 78:153–158
Rogers LA, Forster SM, Pinching A (1989) IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages. Clin Exp Immunol 75:7–11
Rogna S, Puppo F, Torresin A, Stagnaro R, Setti M, Pierri I, Orlando G, Indiveri F (1988) Plasmapheresis followed by immunglobulin infusion for treatment of human immunodeficiency virus (HIV) infected patients with hypergammaglobulinaemia. Int J Immunotherapy 4:229–234
Saint-Marc T, Touraine J-I, Berra N (1992) Beneficial effects of intravenous immunoglobulins in AIDS. Lancet 340:1347
Schrappe-Bächer M, Rasokat H, Bauer P, Bendick C, Bube FW, Degenhardt St, Fätkenheuer G, Heiniger HJ, Heitmann K, Imbach P, Krickeberg H, Mauff G, Meller M, Mertens T, Morell A, Perret BA, Plum G, Ramon A, Salzberger B, Schaad UB, Siebel E, Späth PJ, Stützer H, Türk D, Krueger GRF (1990) High-dose intravenous immunoglobulins in HIV-1-infected adults with AIDS-related complex and Walter-Reed 5. Vex Sang 59 (Suppl 1):3–14
Silverman BA, Rubinstein A (1985) Serum lactate dehydrogenase levels in adults and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex: possible indicator of B cell lymphoproliferation and disease activity. Am J Med 78:728–736
SPSS Reference Guide (1990) SPSS Inc, Chicago
Suzuki N, Sakane T, Ueda Y, Murakawa Y, Tsunematsu T (1986) Implications for the role of cognate interactions in in vitro human B cell activation by Staphylococcus aureus Cowan I and pokeweed mitogen. J Clin Invest 77:294–300
The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group (1991) Intravenous immuno globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 325:73–80
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jablonowski, H., Sander, O., Willers, R. et al. The use of intravenous immunoglobulins in symptomatic HIV infection. Clin Investig 72, 220–224 (1994). https://doi.org/10.1007/BF00189318
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00189318